Northwest Biotherapeutics Inc. New (NWBO) Stock Quote

Detailed Quote for Northwest Biotherapeutics Inc. New (NWBO)

close 52 Week Information

52 Week High

June 6, 2011

Close: 0.89

52 Week Low

December 6, 2011

Close: 0.32

Today

Last Price
0.35

Change $
0.01

Change %
2.78%

Tick
N/A

Bid
0.30

Bid Size
5,000

Ask
0.54

Ask Size
2,500

Open
0.352

High
0.365

Low
0.35

Prev Close
0.36

Last Trade
2/10/12

Volume
288 k

52 Wk Hi
0.89

52 Wk Low
0.32

Market Cap
52.25 m

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
149,283,254

EPS (TTM)
-0.39

PE Ratio
N/A

close Exchange Information Listed On OTC Bulletin Board Consolidated (OTCBB) Exchange
OTCBB

News and Media for Northwest Biotherapeutics Inc. New (NWBO)

Sector News | Topic News

News for NWBO

Tue, Jan 10, 2012

8:30 AM

NW Bio to Present Today at the OneMedForum SF 2012 Conference - PR Newswire

Mon, Jan 09, 2012

8:30 AM

NW Bio Reaches 25 Clinical Trial Sites Open and Recruiting By the End of Q4, 2011 - PR Newswire

Mon, Dec 19, 2011

8:30 AM

Northwest Bio Reaffirms Its Freedom to Operate; Refutes Other Parties' Misleading Patent Assertions - PR Newswire

Fri, Dec 02, 2011

9:22 AM

Northwest Bio Implements Major Balance Sheet Clean-Up - PR Newswire

Thu, Nov 17, 2011

8:30 AM

Northwest Bio Announces Transactions for $5.4 Million in New Financing - PR Newswire

Tue, Nov 15, 2011

8:30 AM

Northwest Bio to Present at Society of Neuro-Oncology Annual Meeting - PR Newswire

Tue, Nov 01, 2011

10:38 AM

Northwest Bio Announces Interview of CEO Linda Powers in Today's CEO/CFO Publication - PR Newswire

Tue, Oct 25, 2011

9:52 AM

NORTHWEST BIO Announces Initiation of S&P Coverage, With Publication of First Company Stock Report - PR Newswire

Thu, Oct 06, 2011

8:30 AM

NORTHWEST BIO Announces Positive Third Quarter Progress - PR Newswire

Tue, Oct 04, 2011

8:30 AM

NORTHWEST BIO Will Present at the Second Annual "Cancer Immunotherapy: A Long Awaited Reality Conference" at the New York Academy of Medicine, October 6, 2011 - PR Newswire

Mon, Jul 11, 2011

11:04 AM

Key investments should continue to propel Northwest Biotherapeutics - Accesswire

8:40 AM

"Growing Momentum and Recognition" for Northwest Biotherapeutics Should Continue - Marketwire

Tue, Jun 07, 2011

9:48 AM

Announcements Re-Position Northwest Biotherapeutics - Marketwire

Mon, Jun 06, 2011

10:22 AM

Report: Emerging Cancer Vaccines Vying for Attention From Investors - Marketwire

Wed, May 18, 2011

9:21 AM

Northwest Biotherapeutics' Partnership Announcement Is Significant in Several Ways - Marketwire

Thu, Apr 28, 2011

8:23 AM

Report: Northwest Biotherapeutics Won't Be Staying Under the Radar for Long - Marketwire

Mon, Apr 04, 2011

12:19 PM

Trade Alerts Issued for TapImmune and Northwest Biotherapeutics - Marketwire

Thu, Aug 26, 2010

1:22 AM

Brain Tumor Advocactes Remember Ted Kennedy One Year Later - Accesswire

1:22 AM

Brain Tumor Advocactes Remember Ted Kennedy One Year Later - Accesswire

Thu, Jul 15, 2010

8:11 AM

Best cancer vaccine? Answer may surprise you. - Accesswire

More News for NWBO >>

Tags for Northwest Biotherapeutics Inc. New

Research stocks or mutual funds related to Northwest Biotherapeutics Inc. New by keywords or tags. Find companies that have a similar focus to NWBO. The keywords below have been associated to NWBO by either user submission or electronic means.

bush brain mortgage brain advanced therapy clinical trial logistics clinical trial enrollment clinical trials liability brain gain brain improvement brain teasers clinical research trial clinical research software clinical trials data brain train pivotal therapy system clinical cost prostate treatment brain pictures prostate perform brain boosters clinical trial education clinical diagnostics brain cells outsourcing clinical trials brain the radiation therapy prostate mesothelioma treatment options clinical research training clinical trial jobs cancer prostate brain teasers puzzle brain anatomical model brain nutrient phase iii clinical trials brain stem gliomas sheep brain dissection pancreatic cancer clinical research research sec filings lupus brain laparoscopic prostate surgery clinical trial india follicular dendritic cell brain guide hormonal therapy sec championship phase 3 clinical trials buy brain age brain functioning allergen immunotherapy human brain model